Skip to main content
Premium Trial:

Request an Annual Quote

SciTegic Signs on Five Software Vendors in New Informatics Consortium

NEW YORK, March 10 (GenomeWeb News) - Accelrys subsidiary SciTegic has introduced a partner program aimed at enlisting independent software vendors to expand the applications of the company's Pipeline Pilot middleware, SciTegic said earlier this week.

 

"SciTegic is opening up its framework to these ISVs so they can make their applications available to our established user base," Matt Hahn, vice president and general manager of SciTegic, said in a statement. "By providing customers with access to a wider range of technologies, Pipeline Pilot will allow its users to further streamline and integrate the tools they use every day."

SciTegic said five scientific software companies are currently signed up as program members: Equbits, Molecular Networks, Virtual Chemistry, ChemNavigator, and Barnard Chemistry.

John Barnard, SciTegic founder-director, said the company is "initially" making its clustering and fingerprint generation technologies available as web services within Pipeline Pilot.

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.